相关实验视频
Updated: May 5, 2026

08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
3.4K
糖酸盐通过调节CXCL10通过PPARα激活可释放的角质细胞来改善亚托皮炎
Yujia Wei1, Xiaomei Zhu1, Shan Lin2
1Department of Dermatology, Huazhong University of Science and Technology Tongji Medical College Tongji Hospital, Wuhan, China.
概括
血清含量低与阿托皮性皮肤炎 (AD) 和增加CXCL10表达有关. 在AD小鼠模型中,葡萄酸治疗通过调节关键信号通路,有效降低了AD小鼠模型中的炎症和症状.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 微量元素的新陈代谢
- 分子生物学分子生物学
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病,受免疫失调和潜在的微量元素的影响.
- 在AD患者中观察到血清缺乏,这表明在疾病的发病过程中发挥了作用.
研究的目的:
- 调查血清微量元素,特别是对亚托皮性皮肤炎发病的影响.
- 探索糖酸盐在治疗阿尔茨海默病中的治疗潜力.
主要方法:
- 在AD患者和对照组中分析血清微元素和基因表达 (CXCL10).
- 在体外对角质细胞的研究和在体内使用AD类皮肤炎小鼠模型的研究.
- 研究了涉及PPARα和STAT信号的分子机制.
主要成果:
- 艾滋病患者的血清含量较低,皮肤上CXCL10表达增加,与缺乏相关.
- 糖酸盐治疗在体外减少了化学反应和CXCL10释放,包括PPARα激活和STAT通路抑制.
- 在小鼠模型中,糖酸盐降低了IgE,缓解了皮肤病变,并减少了CXCL10的表达.
结论:
- 血清的降低与AD病原发生有关,可能是通过调节CXCL10.
- 糖通过PPARα和STAT信号通路减少炎症,证明了AD的治疗潜力.
- 糖酸有效地管理AD类疾病,突出其作为潜在治疗剂的作用.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Acne Infection
94
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
94

